Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2021-02-12 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2021-02-12 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board Meeting to consider the unaudited financial results for the quarter ended December 31, 2020. It references a future event (Board Meeting) and the intention to consider quarterly financial results, but does not contain any actual financial data or results. The document is short (1515 characters) and serves as an announcement rather than a report. According to the rules, such notifications about board meetings and financial results consideration fall under Board/Management Information (MANG).
2021-02-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification titled 'Intimation of Closure of Trading Window' addressed to stock exchanges. It references the Securities and Exchange Board of India regulations related to insider trading and informs about the closure of the trading window from January 1, 2021, until 48 hours after the announcement of quarterly financial results. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1515 characters), and it serves as an official notice rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-01 English
Related Party Transactions
Remuneration Information Classification · 95% confidence The document contains detailed information about key management personnel (KMP), their relatives, and remuneration figures including sitting fees and investments. This type of content aligns with disclosures related to executive compensation and related party transactions. The presence of remuneration details and KMP information strongly suggests this is a Remuneration Information report. The document length is short but contains substantive remuneration data, not just an announcement or certification. Therefore, it fits the Remuneration Information (DEF 14A) category rather than a general regulatory filing or announcement.
2020-11-20 English
Financial Result Updates
Regulatory Filings
2020-11-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Alpa Laboratories Ltd. to stock exchanges about a scheduled Board Meeting to consider the unaudited financial results for the quarter and half year ended September 30, 2020. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document is short (1644 characters) and serves as an announcement of an upcoming event (Board Meeting) rather than containing actual financial results or detailed financial data. It does not contain the financial report itself, nor detailed management discussion or audit information. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the exchanges and shareholders about the meeting and the agenda to consider financial results.
2020-11-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.